Skip to main content
. 2020 Mar 30;20:260. doi: 10.1186/s12885-020-06738-z

Fig. 4.

Fig. 4

Kaplan Meier OS analysis, from date of incident aNSCLC diagnosis by 1 L treatment type. Shows the Kaplan Meier survival estimates from incident aNSCLC diagnosis for the overall aNSCLC patient sample as well as for subgroups based on mutation testing and received 1 L treatments. Log-rank test: Chemotherapy/Mutation positive & targeted therapy: p = 0.011; Chemotherapy/Immunotherapy only p = 0.002; Chemotherapy/No mutation test & targeted therapy: p = 0.570